Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

Open Access 01-04-2010 | Guidelines

Guidelines for the labelling of leucocytes with ^99mTc-HMPAO

Authors: Erik F. J. de Vries, Manel Roca, Francois Jamar, Ora Israel, Alberto Signore

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 4/2010

Abstract

We describe here a protocol for labelling autologous white blood cells with ^99mTc-HMPAO based on previously published consensus papers and guidelines. This protocol includes quality control and safety procedures and is in accordance with current European Union regulations and International Atomic Energy Agency recommendations.

Guidelines on current good radiopharmacy practice (cGRPP) in the preparation of radiopharmaceuticals. EANM Radiopharmacy committee. Eur J Nucl Med Mol Imaging 2009 (in press), https://www.eanm.org/scientific_info/guidelines/gl_radioph_cgrpp.pdf

Ak I, Vardereli E, Durak B, Gülbaş Z, Basaran N, Stokkel MPM, et al. Labeling of mixed leukocytes with 99mTc-HMPAO causes severe chromosomal aberrations in lymphocytes. J Nucl Med 2002;43:203–6.PubMed

Annovazzi A, Bagni B, Burroni L, D′Alessandria C, Signore A. Nuclear medicine imaging of inflammatory/infective disorders of the abdomen. Nucl Med Commun 2005;26:657–64.CrossRefPubMed

Capriotti G, Chianelli M, Signore A. Nuclear medicine imaging of diabetic foot infection: results of meta-analysis. Nucl Med Commun 2006;27:757–64.CrossRefPubMed

Cascini GL, De Palma D, Matteucci F, Biggi A, Rambaldi PF, Signore A, et al. Fever of unknown origin, infection of subcutaneous devices, brain abscesses and endocarditis. Nucl Med Commun 2006;27:213–22.CrossRefPubMed

Danpure HJ, Osman S. A review of methods of separating and radiolabelling human leucocytes. Nucl Med Commun 1988;9:681–5.PubMed

Danpure HJ, Osman S, Carroll MJ. The development of a clinical protocol for the radiolabelling of mixed leucocytes with 99Tcm-hexamethylpropyleneamine oxime. Nucl Med Commun 1988;9:465–75.PubMedCrossRef

Jacquier-Sarlins MR, Polla BS, Slosman DO. Oxido-reductive state: the major determinant for cellular retention of technetium-99m-HMPAO. J Nucl Med 1996;37:1413–6.

Morrissey GJ, Powe JE. Routine application of fractional HMPAO stored at -70C for WBC scintigraphy. J Nucl Med 1993;34:151–5.PubMed

10.

Palestro CJ, Brown ML, Forstrom LA, Greenspan BS, McAfee JG, Royal HD, Schauwecker DS, Seabold JE, Signore A. Society of Nuclear Medicine Procedure Guideline for 99mTc-exametazime (HMPAO)-labeled leukocyte scintigraphy for suspected infection/inflammation, version 3.0, 2004, http://interactive.snm.org/docs/HMPAO_v3.pdf

11.

Peters AM, Osman S, Henderson BL, Kelly JD, Danpure HJ, Hawker RJ, et al. Clinical experience with 99mTc-hexamethylpropyleneamineoxime for labelling leukocytes and imaging inflammation. Lancet 1986;8513:946–9.CrossRef

12.

Prandini N, Lazzeri E, Rossi B, Erba P, Parisella MG, Signore A. Nuclear medicine imaging of bone infections. Nucl Med Commun 2006;27:633–44.CrossRefPubMed

13.

Roca M, Martín-Comín J, Becker W, Bernardo-Filho M, Gutfilen B, Moisan A, et al. A consensus protocol for white blood cell labelling with technetium-99m hexamethylpropylene amine oxime. Eur J Nucl Med 1998;25:797–9.CrossRefPubMed

14.

Roddie ME, Peters AM, Danpure HJ, Osman S, Henderson BL, Lavender JP, et al. Inflammation: imaging with Tc-99m HMPAO-labeled leukocytes. Radiology 1988;166:767–72.PubMed

15.

Sampson CB, Solanki C, Barber RW. 99Tcm-exametazime-labelled leucocytes: effect of volume and concentration of exametazime on labelling efficiency, and clinical protocol for high efficiency multi-dose radiolabelling. Nucl Med Commun 1991;12:719–23.PubMedCrossRef

16.

Saverymuttu SH, Peters AM, Dampure HJ, et al. Lung transit of 111Indium-labelled granulocytes. Relationship to labeling technique. Scand J Haematol 1983;30:151–60.PubMed

17.

Solanki KK, Mather SJ, Al Janabi M, Britton KE. A rapid method for the preparation of 99Tcm hexametazime-labelled leucocytes. Nucl Med Commun 1988;9:753–61.CrossRefPubMed

18.

Suess E, Huck S, Reither H, Hörtnagl H, Angelberger P. Uptake mechanism of technetium-99m-d, 1-HMPAO in cell cultures of the dissociated postnatal rat cerebellum. J Nucl Med 1992;33:108–14.PubMed

19.

Thierens HMA, Vral AM, Van Haelst JP, Van de Wiele C, Schelstraete KHG, de Ridder LIF. Lymphocyte labeling with technetium-99m-HMPAO: a radiotoxicity study using the micronucleus assay. J Nucl Med 1992;33:1167–74.PubMed

20.

Piera C, Vázquez A, Hernández MA, Plancha MC, Ruiz A, Mateos JJ, et al. Método rápido de marcaja de leucocitos con 99mTc HM-PAO. Rev Esp Med Nucl 2002;21:343–8.PubMed

21.

UK Radiopharmacy Group. Guidelines for the safe preparation of radiolabelled blood cells. http://www.ukrg.org.uk/

22.

Yeo C, Saunders N, Locca D, Flett A, Preston M, Brookman P, et al. Ficoll-Paque versus Lymphoprep: a comparative study of two density gradient media for therapeutic bone marrow mononuclear cell preparations. Regen Med 2009;4:689–96.CrossRefPubMed

Title: Guidelines for the labelling of leucocytes with 99mTc-HMPAO
Authors: Erik F. J. de Vries
Manel Roca
Francois Jamar
Ora Israel
Alberto Signore
Publication date: 01-04-2010
Publisher: Springer-Verlag
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 4/2010
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-010-1394-4

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Guidelines for the labelling of leucocytes with ^99mTc-HMPAO

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2010

Guidelines for the labelling of leucocytes with 111In-oxine

Highlights of the EANM Congress Barcelona 2009: increasing our impact in diagnostic imaging

Ultrafast nuclear myocardial perfusion imaging on a new gamma camera with semiconductor detector technique: first clinical validation

The added value of multislice SPECT/CT in patients with equivocal bony metastasis from carcinoma of the prostate

PET/CT imaging of osteoblastic bone metastases with 68Ga-bisphosphonates: first human study

Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma